Skip to main content

Peer Review reports

From: Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients

Original Submission
3 Aug 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Sep 2023 Reviewed Reviewer Report - Pooria Safarzadeh Kozani
21 Sep 2023 Reviewed Reviewer Report
21 Sep 2023 Reviewed Reviewer Report
4 Oct 2023 Author responded Author comments - Changsong Wang
Resubmission - Version 3
4 Oct 2023 Submitted Manuscript version 3
Publishing
17 Oct 2023 Editorially accepted
23 Oct 2023 Article published 10.1186/s12885-023-11536-4

You can find further information about peer review here.

Back to article page